Cargando…
MIR1246 in body fluids as a biomarker for pancreatic cancer
Pancreatic cancer is an aggressive tumor associated with poor survival, and early detection is important to improve patient outcomes. In the present study, we examined MIR1246 expression as a biomarker of pancreatic cancer. Total RNA was extracted from serum, urine and saliva samples from healthy su...
Autores principales: | Ishige, Fumitaka, Hoshino, Isamu, Iwatate, Yosuke, Chiba, Satoshi, Arimitsu, Hidehito, Yanagibashi, Hiroo, Nagase, Hiroki, Takayama, Wataru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250935/ https://www.ncbi.nlm.nih.gov/pubmed/32457495 http://dx.doi.org/10.1038/s41598-020-65695-6 |
Ejemplares similares
-
Radiogenomics for predicting p53 status, PD-L1 expression, and prognosis with machine learning in pancreatic cancer
por: Iwatate, Yosuke, et al.
Publicado: (2020) -
Transcriptomic analysis reveals high ITGB1 expression as a predictor for poor prognosis of pancreatic cancer
por: Iwatate, Yosuke, et al.
Publicado: (2022) -
Machine learning with imaging features to predict the expression of ITGAV, which is a poor prognostic factor derived from transcriptome analysis in pancreatic cancer
por: Iwatate, Yosuke, et al.
Publicado: (2022) -
Radiogenomics predicts the expression of microRNA-1246 in the serum of esophageal cancer patients
por: Hoshino, Isamu, et al.
Publicado: (2020) -
Cell-free microRNA-1246 in different body fluids as a diagnostic biomarker for esophageal squamous cell carcinoma
por: Hoshino, Isamu, et al.
Publicado: (2021)